 |
|
Disparities in Colon Cancer Screening in the Medicare Population
Ashwin N. Ananthakrishnan, MD, MPH;
Kenneth G. Schellhase, MD, MPH;
Rodney A. Sparapani, MS;
Purushottam W. Laud, PhD;
Joan M. Neuner, MD, MPH
Arch Intern Med. 2007;167(3):258-264.
Background Colorectal cancer is the third most common cancer in the United States, but the rate of screening remains low. Since 2001, Medicare has provided coverage of colonoscopy for colorectal cancer screening in individuals at average risk, but little is known about the effect of this coverage on screening or disparities in screening practices.
Methods We examined the Medicare physician/supplier billing claims file for New York, Florida, and Illinois for the years 2002 and 2003. Using a previously employed algorithm, we identified the rates of colorectal screening tests in individuals at average risk. We performed multivariate logistic regression analysis to calculate the effects of sex, racial/ethnic, and socioeconomic characteristics on screening. We also looked for interactions between socioeconomic and demographic variables.
Results A total of 596 470 Medicare beneficiaries were included in the study. Approximately 18.3% of the population had undergone a screening colon test during the study period. Nonwhite persons were less likely to be screened for colorectal cancer than were white persons (relative risk [RR], 0.52; 95% confidence interval [CI], 0.50-0.53). The lowest RR of screening colonoscopy in women compared with men was in the oldest age group and the highest income tertile (RR for whites, 0.64; 95% CI, 0.59-0.70). Higher income level was associated with screening colonoscopy in white patients (men: RR, 1.19; 95% CI, 1.14-1.25; women: RR, 1.09; 95% CI, 1.05-1.15) but not in nonwhite patients (men: RR, 0.97; 95% CI, 0.78-1.22; women: RR, 0.94; 95% CI, 0.78-1.14).
Conclusion Despite the expansion of Medicare coverage for colorectal cancer screening, there still remain significant disparities between sex and racial/ethnic groups in screening practices.
Author Affiliations: Departments of Medicine (Drs Ananthakrishnan and Neuner) and Family and Community Medicine (Dr Schellhase), and Health Policy Institute, Center for Patient Care and Outcomes Research, and Division of Biostatistics (Drs Schellhase, Laud, and Neuner and Mr Sparapani), Medical College of Wisconsin, Milwaukee.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Screening for Colorectal Cancer: A Targeted, Updated Systematic Review for the U.S. Preventive Services Task Force
Whitlock et al.
ANN INTERN MED 2008;0:0000605-200811040-00245-E-245.
ABSTRACT
| FULL TEXT
Prevalence of Colon Polyps Detected by Colonoscopy Screening in Asymptomatic Black and White Patients
Lieberman et al.
JAMA 2008;300:1417-1422.
ABSTRACT
| FULL TEXT
Factors Associated with Racial/Ethnic Differences in Colorectal Cancer Screening
Shokar et al.
J Am Board Fam Med 2008;21:414-426.
ABSTRACT
| FULL TEXT
Perceived Medical Discrimination and Cancer Screening Behaviors of Racial and Ethnic Minority Adults
Crawley et al.
Cancer Epidemiol. Biomarkers Prev. 2008;17:1937-1944.
ABSTRACT
| FULL TEXT
Determinants of Racial/Ethnic Colorectal Cancer Screening Disparities
Jerant et al.
Arch Intern Med 2008;168:1317-1324.
ABSTRACT
| FULL TEXT
The Effect of Oral Sodium Phosphate Drug Products on Renal Function in Adults Undergoing Bowel Endoscopy
Khurana et al.
Arch Intern Med 2008;168:593-597.
ABSTRACT
| FULL TEXT
History of Allergy and Reduced Incidence of Colorectal Cancer, Iowa Women's Health Study
Prizment et al.
Cancer Epidemiol. Biomarkers Prev. 2007;16:2357-2362.
ABSTRACT
| FULL TEXT
Disparities in Colorectal Cancer Screening
JWatch Gastroenterology 2007;2007:1-1.
FULL TEXT
|
